IGFBP1 and colorectal carcinoma: Prospective epidemiological studies indicate that higher circulating concentrations of IGF-I and II and reduced concentrations of insulin-like growth factor-I-binding proteins IGFBP-1 and IGFBP-2 are associated with an increased CRC risk [68].